학술논문
Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study
Document Type
Article
Author
Source
In Atherosclerosis August 2021 331:20-27
Subject
Language
ISSN
0021-9150